|
|
||||||||
J Thorac Cardiovasc Surg 2008;135:347-354
© 2008 The American Association for Thoracic Surgery
Surgery for Congenital Heart Disease |

a Department of Cardiology, Childrens Hospital Boston, Boston, Mass
b Department of Cardiovascular Surgery, Childrens Hospital Boston, Boston, Mass
c Department of Neurology, Childrens Hospital Boston, Boston, Mass
d Department of Anesthesiology, Childrens Hospital Boston, Boston, Mass
e Department of Radiology, Childrens Hospital Boston, Boston, Mass
f Department of Pediatrics, Childrens Hospital Boston, Boston, Mass
g Department of Surgery, Harvard Medical School, Boston, Mass
h Department of Pediatrics, Harvard Medical School, Boston, Mass
i Department of Anesthesia, Harvard Medical School, Boston, Mass
j Department of Neurology, Harvard Medical School, Boston, Mass
k Department of Radiology Harvard Medical School, Boston, Mass
l Department of Biostatistics, Harvard School of Public Health, Boston, Mass.
Received for publication October 11, 2006; revisions received January 9, 2007; accepted for publication January 29, 2007. * Address for reprints: Jane W. Newburger, MD, MPH, Department of Cardiology, Childrens Hospital Boston, 300 Longwood Ave, Boston, MA 02115. (Email: jane.newburger{at}cardio.chboston.org).
Objectives: We previously reported that postoperative hemodynamics and developmental outcomes were better among infants randomized to a higher hematocrit value during hypothermic cardiopulmonary bypass. However, worse outcomes were concentrated in patients with hematocrit values of 20% or below, and the benefits of hematocrit values higher than 25% were uncertain.
Methods: We compared perioperative hemodynamics and, at 1 year, developmental outcome and brain magnetic resonance imaging in a single-center, randomized trial of hemodilution to a hematocrit value of 25% versus 35% during hypothermic radiopulmonary bypass for reparative heart surgery in infants undergoing 2-ventricle repairs without aortic arch obstruction.
Results: Among 124 subjects, 56 were assigned to the lower-hematocrit strategy (24.8% ± 3.1%, mean ± SD) and 68 to the higher-hematocrit strategy (32.6% ± 3.5%). Infants randomized to the 25% strategy, compared with the 35% strategy, had a more positive intraoperative fluid balance (P = .007) and lower regional cerebral oxygen saturation at 10 minutes after cooling (P = .04) and onset of low flow (P = .03). Infants with dextro-transposition of the great arteries in the 25% group had significantly longer hospital stay. Other postoperative outcomes, blood product usage, and adverse events were similar in the treatment groups. At age 1 year (n = 106), the treatment groups had similar scores on the Psychomotor and Mental Development Indexes of the Bayley Scales; both groups scored significantly worse than population norms.
Conclusions: Hemodilution to hematocrit levels of 35% compared with those of 25% had no major benefits or risks overall among infants undergoing 2-ventricle repair. Developmental outcomes at age 1 year in both randomized groups were below those in the normative population.
Related Articles
J. Thorac. Cardiovasc. Surg. 2008 135: 240-242.
J. Thorac. Cardiovasc. Surg. 2008 135: 355-360.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |